Hims & Hers Health (NYSE: HIMS) Facing Securities Class Action After FTC Lawsuit Reveal Drives Stock Sharply Lower

Impact · against what's priced in

The announcement of a securities class action lawsuit against Hims & Hers is marginally negative, as it introduces a new legal expense layer atop the already priced-in FTC regulatory shock. For other mentioned entities like INV and YSS, the news is not applicable to this specific Hims-related litigation.

HIMS−0.20

Not in the price yet

The price assumes

A clean resolution to the FTC and class-action lawsuits